Clinical Trials Logo

Clinical Trial Summary

This is a retrospective study that follows the clinical evolution, the pregnancy and the post-partum perioad of female patients with Congenital Myasthenic Syndrome.


Clinical Trial Description

The aim of this study is to better understand the action of hormonal factors that are presumably incriminated for the fluctuation of the disease. The investigators would also like to better adress the issues of women with Congenital Myasthenic Syndrome, who desire a pregnancy : the possibility of decompensation, the problems that can arise during the course of the childbearing, the risk of foetal malformations. ;


Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT01474980
Study type Observational
Source Institut de Myologie, France
Contact
Status Completed
Phase N/A
Start date January 2010
Completion date October 2011

See also
  Status Clinical Trial Phase
Completed NCT01203592 - Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes Phase 1
Recruiting NCT01403402 - Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Recruiting NCT05687474 - Baby Detect : Genomic Newborn Screening
Completed NCT05408702 - Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes
Not yet recruiting NCT06436742 - A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS) Phase 1
Recruiting NCT06078553 - A Natural History Study in Participants With DOK7 Congenital Myasthenic Syndromes (CMS)
No longer available NCT03062631 - Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia
No longer available NCT02189720 - Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myasthenic Syndrome
Approved for marketing NCT00872950 - 3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)